The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Eris Lifesciences enters into term loan agreement with Citi Bank
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
